Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eritoran for Lipid-Induced Insulin Resistance
NCT02321111Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- Jan 2015
- Primary completion
- Sep 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eritoran in insulin resistance (IR), sponsored by UT Health San Antonio. Started Jan 2015; status: completed.
02
Drugs
eritoran
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02321111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02321111.